Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Member News
Copy The Link to the  Article
Abcuro announces pre-clinical data on new immuno-oncology target
First in vivo validation of KLRG1 as a new cancer immunotherapy target
Copy The Link to the  Article

Related or similar articles

View more News
May 9, 2019

Labshares Newton Selects Savran Technologies as Winner of First Launch@Labshares Competition Valued at $50K

Second Launch@Shares Competition Announced in Collaboration with MTTC/MALSI Conference and MassBio’s MassCONNECT Program
Press Releases
June 13, 2024

Advancing Science at Labshares: Diagonal Therapeutics' Journey

Labshares News
October 31, 2018

Labshares Newton Launches Near Capacity and Announces Expansion Plans

Labshares Newton, an office and laboratory incubator for emerging biotechnology and life science companies, announced the launch of its first location in Newton.
Press Releases